Promacta 12.5 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FKPNZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,252
Award facts
- Contract value 100% obligated
- $13,251.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Promacta 12.5 mg tablets (30-count units) under a firm fixed price contract valued at $13,251.75, with completion targeted for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion master contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio with the DLA Medical Supply Chain demonstrates consistent capability to meet procurement requirements through open competition, with delivery orders spanning diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This award for Promacta, a thrombopoietin receptor agonist used in hematological treatment, reflects the company's ongoing role as a primary pharmaceutical supplier supporting military medical operations and readiness.
Quick answers
Who was awarded contract SPE2DB25FKPNZ?
SPE2DB25FKPNZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FKPNZ worth?
The government has obligated $13,252 on SPE2DB25FKPNZ.
Is contract SPE2DB25FKPNZ an order under another contract?
Yes. SPE2DB25FKPNZ is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKPNZ competed?
The extent of competition for SPE2DB25FKPNZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award